OSF Cancer Institute is one of the chosen few participants in an exciting new cancer treatment trial program. The founder of ...
Recently published research from the University of Oklahoma and the University of Tulsa shows that a new therapy for children ...
The framework seeks to make the UK a desirable clinical trials location by expediting approvals and raising participant ...
Keros will host an update call and webcast today, December 12, 2024, at 8:00 a.m. ET LEXINGTON, Mass., Dec. 12, 2024 (GLOBE ...
Kara Kelly, MD, chair of pediatrics, Roswell Park Oishei Children's Cancer and Blood Disorders Program, shares findings on ...
On November 8, the Department of Labor (DOL) issued an opinion letter addressing an interesting question under the Family and ...
An investigation published in The BMJ raises new concerns over the landmark clinical trial (PLATO) that was used to gain ...
Tony Newberne is a high-risk myeloma survivor. He is also a CPT, dietary manager, and patient advocate for several nonprofits ...
As a result of the preliminary STOMP data – which gave the chances of a positive outcome from the study at less than 1% – the ...
The data include an interim look at the dose-escalation portion of a phase 2 trial assessing the adenosine A2A receptor ...
Among patients with hormone receptor (HR)-positive, HER2-negative, low-risk ductal carcinoma in situ (DCIS), those who underwent active monitoring had similar two-year invasive ipsilateral breast ...
Enlivex has gained approval from the Israeli regulator approval to commence a Phase I trial of Allocetra in people with TMJ osteoarthritis.